Dopamine and serotonin imbalances in the left anterior cingulate and pyriform cortices following the repeated intermittent administration of cocaine

Neuroscience

Volumn 89, Issue 3, 1999, Pages 701-715

  Heidbreder, C A ^a   Oertle, T ^a   Feldon, J ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Cingulate cortex; Cocaine; Dopamine; Interhemispheric coupling; Pyriform cortex; Serotonin

Indexed keywords

COCAINE; DOPAMINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CINGULATE GYRUS; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG DEPENDENCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; SEROTONIN RELEASE;

ACETYLCHOLINE; AFFERENT PATHWAYS; ANIMALS; BEHAVIOR, ANIMAL; CAUDATE NUCLEUS; COCAINE; DOMINANCE, CEREBRAL; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; GYRUS CINGULI; MALE; MESENCEPHALON; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; OLFACTORY PATHWAYS; RATS; RATS, WISTAR; SEROTONIN;

EID: 0032908659     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00339-X     Document Type: Article

References (92)

1. Ackerman J.M., White F.J. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117:1990;181-187.
2. Bannon M.J., Roth R.H. Pharmacology of mesocortical dopamine neurons. Pharmac. Rev. 35:1983;53-68.
3. Bannon M.J., Wolf M.E., Roth R.H. Pharmacology of dopamine neurons innervating the prefrontal, cingulate and piriform cortices. Eur. J. Pharmac. 92:1983;119-125.
4. Bartlett E., Hallin A., Chapman B., Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability? Neuropsychopharmacology. 16:1997;77-82.
5. Baumann M.H., Raley T.J., Partilla J.S., Rothman R.B. Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study. Synapse. 14:1993;40-50.
6. Baumann M.H., Becketts K.M., Rothman R.B. Evidence for alterations in presynaptic serotonergic function during withdrawal from chronic cocaine in rats. Eur. J. Pharmac. 282:1995;87-93.
7. Beani L., Bianchi C. The extraction of acetylcholine in small samples of cerebral tissue. J. Pharm. Pharmac. 15:1963;281-282.
8. Beaumont G., Dimond S. Brain disconnection and schizophrenia. Br. J. Psychiat. 123:1973;661-662.
9. Beck C.H., Fibiger H.C. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J. Neurosci. 15:1995;709-720.
10. Bickerdike M.J., Abercrombie E.D. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J. Pharmac. exp. Ther. 282:1997;818-826.
11. Borowski T.B., Kokkinidis L. Cocaine preexposure sensitizes conditioned fear in a potentiated acoustic startle paradigm. Pharmac. Biochem. Behav. 49:1994;935-942.
12. Brady K.T., Lydiard B., Malcolm R., Balliger J.C. Cocaine-induced psychosis. J. clin. Psychiat. 52:1991;509-512.
13. Cador M., Bijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience. 65:1995;385-395.
14. Carlezon W.A. Jr., Devine D.P., Wise R.A. Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology. 122:1995;194-197.
15. Carlson J.N., Fitzgerald L.W., Keller R.W., Glick S.D. Lateralized changes in prefrontal cortical dopamine activity induced by controllable and uncontrollable stress in the rat. Brain Res. 630:1993;178-187.
16. Carlson J.N., Visker K.E., Keller R.W. Jr., Glick S.D. Left and right 6-hydroxydopamine lesions of the medial prefrontal cortex differentially alter subcortical dopamine utilization and the behavioral response to stress. Brain Res. 711:1996;1-9.
17. Clineschmidt B.V., Martin P.R., Bunting P.R., Rapp N. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug. dev. Res. 2:1982;123-134.
18. 1 receptors localised in the striatum. J. Neurochem. 59:1992;1555-1557.
19. Coplan J.D., Gorman J.M., Klein D.F. Serotonin related functions in panic-anxiety: a critical overview. Neuropsychopharmacology. 6:1992;189-200.
20. Crawford C.A., McDougall S.A., Bolanos C.A., Hall S., Berger S.P. The effects of the kappa agonist U-50,488H on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology. 120:1995;392-399.
21. Datiche F., Catarelli M. Catecholamine innervation of the piriform cortex: a tracing and immunohistochemical study in the rat. Brain Res. 710:1996;69-78.
22. Datiche F., Luppi P.H., Cattarelli M. Serotonergic and non-serotonergic projections from the raphe nuclei to the piriform cortex in the rat: a cholera toxin B subunit (Ctb) and 5-HT immunohistochemical study. Brain Res. 671:1995;27-37.
23. DeBoer P., Abercrombie E.D. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. J. Pharmac. exp. Ther. 277:1996;775-783.
24. Denenberg V.H. General systems theory, brain organization, and early experience. Am. J. Physiol. 238(Regulatory Integrative Comp. Physiol. 7):1980;R3-R13.
25. Denenberg V.H. Hemispheric laterality in animals and the effects of early experience. Behav. Brain Sci. 4:1981;1-49.
26. Denenberg V.H. Lateralization of function in rats. Am. J. Physiol. 245(Regulatory Integrative Comp. Physiol. 14):1983;R505-R509.
27. Denenberg V.H., Rosen G.D. Interhemispheric coupling coefficients: sex differences in brain neurochemistry. Am. J. Physiol. 245(Regulatory Integrative Comp. Physiol. 14):1983;R151-R153.
28. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. natn. Acad. Sci. U.S.A. 85:1988;5274-5278.
29. Dworkin S.I., Co C., Smith J.E. Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res. 682:1995;116-126.
30. Forloni G., Bidzinski A., Fusi R., Ladinsky H., Consolo S. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation. Life Sci. 41:1987;1717-1723.
31. Galloway M.P. Regulation of dopamine and serotonin synthesis by acute administration of cocaine. Synapse. 6:1990;63-72.
32. Gellman R.L., Aghajanian G.K. Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antopsychotic drugs. Neuroscience. 58:1994;515-525.
33. George M.S., Ketter T.A., Post R.M. SPECT and PET imaging in mood disorders. J. clin. Psychiat. 54:1993;6-13.
34. George M.S., Ketter T.A., Post R.M. Prefrontal cortex dysfunction in clinical depression. Depression. 2:1994;59-72.
35. Glick S.D., Badalamenti J.I. Sex differences in reward asymmetry and effects of cocaine. Neuropharmacology. 25:1986;633-637.
36. Glick S.D., Jerussi T.P., Waters P.H. Amphetamine-induced changes in striatal dopamine and acetylcholine levels and relationship to rotation (circling behavior) in rats. Biochem. Pharmac. 23:1974;3223-3225.
37. Glick S.D., Hinds P.A., Shapiro R.M. Cocaine-induced rotation: sex differences between left- and right-sided rats. Science. 221:1983;775-777.
38. Glick S.D., Raucci J., Wang S., Keller R.W. Jr., Carlson J.N. Neurochemical predisposition to self-administer cocaine in rats: individual differences in dopamine and its metabolites. Brain Res. 653:1994;148-154.
39. Goeders N.E., Smith J.E. Cortical dopaminergic involvement in cocaine reinforcement. Science. 221:1983;773-775.
40. Hadfield M.G. Cocaine. Selective regional effects on central monoamines. Molec. Neurobiol. 11:1995;47-53.
41. Hammer R.P., Cooke E.S. Gradual tolerance of metabolic activity is produced in mesolimbic regions by chronic cocaine treatment, while subsequent cocaine challenge activates extrapyramidal regions of rat brain. J. Neurosci. 14:1994;4289-4298.
42. Hatta T., Yamamoto M., Kawabata Y. Functional hemispheric differences in schizophrenia: interhemispheric transfer deficit or selective hemispheric dysfunction. Biol. Psychiat. 19:1984;1027-1036.
43. Heidbreder C., Shippenberg T.S. Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse. 24:1996;182-192.
44. Heidbreder C., Thompson A.C., Shippenberg T.S. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J. Pharmac. exp. Ther. 276:1996;490-502.
45. Henry D.J., Greene M.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J. Pharmac. exp. Ther. 251:1989;833-839.
46. Hurd Y.L., Weiss F., Koob G.F., Ungerstedt U. The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. Neurosci. Lett. 109:1990;227-233.
47. 1 receptors. Eur. J. Pharmac. 229:1992;265-267.
48. Johnson R.G., Fiorella D., Rabin R.A. Effects of chronic cocaine administration on the serotonergic system in the rat brain. Pharmac. Biochem. Behav. 46:1993;289-293.
49. Kahn R.S., van Praag H.M. Panic disorder: a biological perspective. Eur. Neuropsychopharmac. 2:1992;1-20.
50. Kalivas P.W., Duffy P. The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 5:1990;48-58.
51. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine II. Dopamine perikarya. J. Neurosci. 13:1993;276-284.
52. Kalivas P.W., Duffy P., Dumars L.A., Skinner C. Neurochemical and behavioral effects of acute and daily cocaine. J. Pharmac. exp. Ther. 245:1988;485-492.
53. Kosofsky B.E., Molliver M.E. The serotonergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse. 1:1987;153-168.
54. Loh E.A., Roberts D.C. S. Break points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology. 101:1990;262-266.
55. Löscher W., Annies R., Hönack D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:1991;191-194.
56. Maisonneuve I.M., Keller R.W., Glick S.D. Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats. Brain Res. 535:1990;221-226.
57. Mamounas L.A., Mullen C.A., O'Hearn E., Molliver M.E. Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. comp. Neurol. 314:1991;558-586.
58. Mandell A.J., Knapp S. Asymmetry and mood, emergent properties of serotonin regulation. Archs gen. Psychiat. 36:1979;909-916.
59. 2A receptors on interneurons in rat piriform cortex. J. Pharmac. exp. Ther. 278:1996;1373-1382.
60. Morrow B.A., Roth R.H. Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system. Synapse. 23:1996;174-181.
61. Nordahl T.E., Semple W.E., Gross M., Mellman T.A., Stein M.B., Goyer P., King A.C., Uhde T.W., Cohen R.M. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology. 3:1990;261-272.
62. Ohmori T., Abekawa T., Koyama T. Scopolamine prevents the development of sensitization to metamphetamine. Life Sci. 56:1995;1223-1229.
63. Palkovits M. and Brownsrein M. J. (1988) Maps and Guide to Microdissection of the Rat Brain. Elsevier, New York.
64. Paulson P.E., Robinson T.E. Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology. 104:1991;140-141.
65. Pecknold J.C., Suranyi-Cadotte B., Chang H., Nair N.P. Serotonin uptake in panic disorder and agoraphobia. Neuropsychopharmacology. 1:1988;173-176.
66. Pierce R.C., Reeder D.C., Hicks J., Morgan Z.R., Kalivas P.W. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience. 82:1998;1103-1114.
67. Rao T.S., Kim H.S., Lehmann J., Martin L.L., Wood P.L. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. J. Neurochem. 54:1990;1157-1162.
68. Richardson N.R., Roberts D.C. S. Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration. Life Sci. 49:1991;833-840.
69. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1224.
70. Robertson M.W., Leslie C.A., Bennet J.P. Jr. Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res. 538:1991;337-339.
71. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
72. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
73. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462:1988;211-222.
74. Satel S.L., Southwick S.M., Gawin F.H. Clinical features of cocaine-induced paranoia. Am. J. Psychiat. 148:1991;495-498.
75. Schenk S., Horger B.A., Peltier R., Shelton K. Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Res. 543:1991;227-235.
76. Segal D.S., Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced dopamine response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 571:1992;330-337.
77. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
78. Shahed A.R., Werchan P.M., Stavinoha W.B. Differences in acetylcholine but not choline in brain tissue fixed by freeze fixation or microwave heating. Meth. Find. exp. clin. Pharmac. 18:1996;349-351.
79. Slopsema J.S., van der Gugten J., de Bruin J.P. C. Regional concentrations of noradrenaline and dopamine in the frontal cortex of the rat: dopaminergic innervation of the frontal subareas and lateralization of prefrontal dopamine. Brain Res. 250:1982;197-200.
80. Sullivan R.M., Szechtman H. Asymmetrical influence of mesocortical dopamine depletion on stress ulcer development and subcortical dopamine systems in rats: implications for psychopathology. Neuroscience. 65:1995;757-766.
81. Swanson L. W. (1992) Brain Maps: Structure of the Rat Brain. Elsevier, New York.
82. Umino A., Nishikawa T., Takahashi K. Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem. Int. 26:1995;85-90.
83. Van Ree J.M., Elands J., Kiraly I., Wolterink G. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems. Eur. J. Pharmac. 166:1989;441-452.
84. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine; lack of conditioned effects. Brain Res. 516:1990;99-106.
85. Wang J. Q. and McGinty J. F. (1996) Glutamatergic and cholinergic regulation of immediate-early gene and neuropeptide gene expression in the striatum. In Pharmacological Regulation of Gene Expression in the CNS (ed. Merchant K.), pp. 81-113. CRC, New York.
86. Willick M.L., Kokkinidis L. Cocaine enhances the expression of fear-potentiated startle: evaluation of state-dependent extinction and the shock-sensitization of acoustic startle. Behav. Neurosci. 109:1995;929-938.
87. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6:1996;243-251.
88. Withers N.W., Pulvirenti L., Koob G.F., Gillin J.C. Cocaine abuse and dependence. J. clin. Psychopharmac. 15:1995;63-78.
89. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmac. exp. Ther. 264:1993;249-255.
90. Wong E.H. F., Kemp J.A., Priestly T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. natn. Acad. Sci. U.S.A. 83:1986;7104-7108.
91. Wood P.L., Altar C.A. Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmac. Rev. 40:1988;163-187.
92. Yamamoto M., Hatta T. Cerebral functional asymmetry and MBD children: a synergistic deficit of hemispheres. Int. J. Neurosci. 24:1984;143-148.